Literature DB >> 10807680

[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

D R Thomas1, P J Atkinson, M Ho, S M Bromidge, P J Lovell, A J Villani, J J Hagan, D N Middlemiss, G W Price.   

Abstract

Binding of the 5-HT(7) receptor antagonist radioligand [(3)H]-SB-269970 to human 5-HT(7(a)) receptors expressed in HEK293 cell membranes (h5-HT(7(a))/293) and to guinea-pig cerebral cortex membranes, was characterized and compared with [(3)H]-5-CT binding. [(3)H]-SB-269970 (1 nM) showed full association with h5-HT(7(a))/293 membranes after 40 min. Specific binding at equilibrium represented >90% of total binding and was fully reversible by methiothepin (10 microM), full dissociation occurring by 100 min. The association (k(+1)) and dissociation (k(-1)) rate constants were 0.05 nM(-1)min(-1) and 0.05 min(-1) respectively, giving a K(D) (k(-1)/k(+1)) of 1.0 nM. [(3)H]-SB-269970 bound saturably and apparently monophasically to both h5-HT(7(a))/293 and guinea-pig cortex membranes, with K(D) values of 1.25+/-0.05 and 1.7+/-0.3 nM respectively. The B(max) for [(3)H]-SB-269970 to both h5-HT(7(a))/293 and guinea-pig cortex membranes (5780+/-380 and 125+/-8.2 fmoles mg protein(-1) respectively) was similar to that for [(3)H]-5-CT (6190+/-940 and 143+/-19 fmoles mg protein(-1) respectively). These data suggest that, in each tissue, both radioligands labelled the same population of receptors, which appear to be present in an agonist high affinity state. The profile of compound inhibition of [(3)H]-SB-269970 binding to h5-HT(7(a))/293 and guineapig cortex membranes correlated well (corr. coeff. 0.98) with those for [(3)H]-5-CT binding and were consistent with the profiles reported previously for the human 5-HT(7(a)) and guinea-pig cortex 5-HT(7) receptors using [(3)H]-5-CT. Hill slopes for inhibition of [(3)H]-SB-269970 and [(3)H]-5-CT binding were close to 1, consistent with binding to a single receptor population in both tissues. [(3)H]-SB-269970 represents the first selective 5-HT(7) antagonist radioligand, which should aid further characterization of 5-HT(7) receptors in recombinant and native tissues and help establish their role in brain function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807680      PMCID: PMC1572078          DOI: 10.1038/sj.bjp.0703318

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

Authors:  D R Thomas; P J Atkinson; M Ho; S M Bromidge; P J Lovell; A J Villani; J J Hagan; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor.

Authors:  R Grailhe; C Waeber; S C Dulawa; J P Hornung; X Zhuang; D Brunner; M A Geyer; R Hen
Journal:  Neuron       Date:  1999-03       Impact factor: 17.173

3.  Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain.

Authors:  Z P To; D W Bonhaus; R M Eglen; L B Jakeman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

4.  Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters.

Authors:  M J Duncan; J Short; D L Wheeler
Journal:  Brain Res       Date:  1999-05-22       Impact factor: 3.252

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.

Authors:  D R Thomas; D N Middlemiss; S G Taylor; P Nelson; A M Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization.

Authors:  D E Heidmann; M A Metcalf; R Kohen; M W Hamblin
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

8.  GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors.

Authors:  J M Watson; M J Burton; G W Price; B J Jones; D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1996-10-31       Impact factor: 4.432

9.  Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.

Authors:  A Fletcher; E A Forster; D J Bill; G Brown; I A Cliffe; J E Hartley; D E Jones; A McLenachan; K J Stanhope; D J Critchley; K J Childs; V C Middlefell; L Lanfumey; R Corradetti; A M Laporte; H Gozlan; M Hamon; C T Dourish
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

Review 10.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

View more
  19 in total

1.  [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

Authors:  D R Thomas; P J Atkinson; M Ho; S M Bromidge; P J Lovell; A J Villani; J J Hagan; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Acute Ca(2+)-dependent desensitization of 5-HT(1A) receptors is mediated by activation of protein kinase A (PKA) in rat serotonergic neurons.

Authors:  Y Yao; P J Bergold; N J Penington
Journal:  Neuroscience       Date:  2010-04-25       Impact factor: 3.590

Review 3.  Alternative approaches to modeling hereditary dystonias.

Authors:  Rachel Fremont; Kamran Khodakhah
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition.

Authors:  Liam J Burnham; Anthony H Dickenson
Journal:  J Pharmacol Exp Ther       Date:  2013-01-07       Impact factor: 4.030

6.  The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies.

Authors:  C Roberts; L Allen; C J Langmead; J J Hagan; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species.

Authors:  Francisco J Martín-Cora; Angel Pazos
Journal:  Br J Pharmacol       Date:  2003-12-01       Impact factor: 8.739

8.  A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.

Authors:  Laszlo G Harsing; Ibolya Prauda; Jozsef Barkoczy; Peter Matyus; Zsolt Juranyi
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

9.  The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

Authors:  Gor Sarkisyan; Amanda J Roberts; Peter B Hedlund
Journal:  Behav Brain Res       Date:  2010-01-25       Impact factor: 3.332

10.  Activation of 5-hyrdoxytryptamine 7 receptors within the rat nucleus tractus solitarii modulates synaptic properties.

Authors:  Michael P Matott; David D Kline
Journal:  Brain Res       Date:  2016-01-15       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.